Overexpression of TACE and TIMP3 mRNA in head and neck cancer: association with tumour development and progression

ADAM17 Regulates Epidermal Growth Factor Receptor Expression through the Activation of Notch1 in Non-Small Cell Lung Cancer

(2010) A. Baumgart et al.   CANCER RESEARCH

Sheddase Activity of Tumor Necrosis Factor-  Converting Enzyme Is Increased and Prognostically Valuable in Head and Neck Cancer

(2009) L. Ge et al.   CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION

Transforming Growth Factor   Induces Clustering of HER2 and Integrins by Activating Src-Focal Adhesion Kinase and Receptor Association to the Cytoskeleton

(2009) S. E. Wang et al.   CANCER RESEARCH

Role of ADAMs in Cancer Formation and Progression

(2009) M. J. Duffy et al.   CLINICAL CANCER RESEARCH

TACE-Mediated Ectodomain Shedding of the Type I TGF-β Receptor Downregulates TGF-β Signaling

(2009) Cheng Liu et al.   MOLECULAR CELL

Expression of Tumor Necrosis Factor α Converting Enzyme in Endocrine Cancers

(2008) Tove Kirkegaard et al.   AMERICAN JOURNAL OF CLINICAL PATHOLOGY

ADAM-17 predicts adverse outcome in patients with breast cancer

(2008) P. M. McGowan et al.   ANNALS OF ONCOLOGY

TACE/ADAM-17: A Component of the Epidermal Growth Factor Receptor Axis and a Promising Therapeutic Target in Colorectal Cancer

(2008) N. B. Merchant et al.   CLINICAL CANCER RESEARCH

TIMP-3 and MMP-3 contribute to delayed inflammation and hippocampal neuronal death following global ischemia

(2008) Espen J. Walker et al.   EXPERIMENTAL NEUROLOGY

Prognostic significance of MMP-9 and TIMP-1 serum and tissue expression in breast cancer

(2008) Zheng-Sheng Wu et al.   INTERNATIONAL JOURNAL OF CANCER